Stem Cell Therapies for Inflammatory Bowel Disease
- 6 April 2019
- journal article
- review article
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 21 (4) , 16
Abstract
Stem cell therapies have demonstrated safety and efficacy in the treatment of perianal Crohn’s disease as compared to conventional therapy. Thus, an understanding of their place in the treatment algorithm for inflammatory bowel disease has become imperative as we move into an era of regenerative medicine.Keywords
This publication has 52 references indexed in Scilit:
- Disappointing Durable Remission Rates in Complex Crohnʼs Disease FistulaInflammatory Bowel Diseases, 2014
- Practice Parameters for the Management of Perianal Abscess and Fistula-in-AnoDiseases of the Colon & Rectum, 2011
- Current considerations in the management of rectovaginal fistula from Crohn’s diseaseColorectal Disease, 2008
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Outcomes of Primary Repair of Anorectal and Rectovaginal Fistulas Using the Endorectal Advancement FlapDiseases of the Colon & Rectum, 2002
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Surgical approaches to low anovaginal fistula in crohn's diseaseThe American Journal of Surgery, 1997
- Treatment of anovaginal fistulas with an anocutaneous flap in patients with Crohn's diseaseInternational Journal of Colorectal Disease, 1993
- Anovaginal and rectovaginal fistulas in Crohn's diseaseDiseases of the Colon & Rectum, 1988
- Anorectal Crohn's diseaseDiseases of the Colon & Rectum, 1985